---
figid: PMC8820467__fcell-10-812081-g002
figtitle: Canonical Wnt/Beta-Catenin Pathway in Regulating Chondrocytic Hypertrophy
  in Mesenchymal Stem Cell-Based Cartilage Tissue Engineering
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8820467
filename: fcell-10-812081-g002.jpg
figlink: /pmc/articles/PMC8820467/figure/F2/
number: F2
caption: 'Interactions of Wnt/β-catenin signaling with other molecules/pathways in
  governing chondrogenic hypertrophy in MSC chondrogenesis. LRP5/6: Lipoprotein Receptor-Related
  Protein 5/6; FZD: Frizzled; ALK1: Activin Receptor-Like kinase 1; CD105: Endoglin;
  TGFR2: TGF-Receptor 2; PTCH: Patched; SMO: Smoothened; GlI: Cubitus interruptus;
  MEF2: Myocyte enhancer factor; DC: Destruction Complex; APC: Adenomatous Polyposis
  Coli; CK1: Casein kinase 1; GSK3: Glycogen synthase kinase 3; EZH2: Zeste homologue
  2; DOT1L: Disruptor of telomeric silencing 1-like; HDAC4: Histone deacetylase 4;
  IHH: Indian Hedgehog; YAP: Yes-associated protein; SIRT1: Silent mating type information
  regulator 2 homolog 1; XAV939, IWP-2, PKF and DKK1 are representative Wnt/β-catenin
  inhibitors in suppressing hypertrophy.'
papertitle: Role of Canonical Wnt/β-Catenin Pathway in Regulating Chondrocytic Hypertrophy
  in Mesenchymal Stem Cell-Based Cartilage Tissue Engineering.
reftext: Xueqi Wang, et al. Front Cell Dev Biol. 2022;10:812081.
year: '2022'
doi: 10.3389/fcell.2022.812081
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media S.A.
keywords: mesenchymal stem cells | hyaline cartilage | chondrocytic hypertrophy |
  chondrogenesis | cartilage tissue engineering
automl_pathway: 0.9623722
figid_alias: PMC8820467__F2
figtype: Figure
redirect_from: /figures/PMC8820467__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8820467__fcell-10-812081-g002.html
  '@type': Dataset
  description: 'Interactions of Wnt/β-catenin signaling with other molecules/pathways
    in governing chondrogenic hypertrophy in MSC chondrogenesis. LRP5/6: Lipoprotein
    Receptor-Related Protein 5/6; FZD: Frizzled; ALK1: Activin Receptor-Like kinase
    1; CD105: Endoglin; TGFR2: TGF-Receptor 2; PTCH: Patched; SMO: Smoothened; GlI:
    Cubitus interruptus; MEF2: Myocyte enhancer factor; DC: Destruction Complex; APC:
    Adenomatous Polyposis Coli; CK1: Casein kinase 1; GSK3: Glycogen synthase kinase
    3; EZH2: Zeste homologue 2; DOT1L: Disruptor of telomeric silencing 1-like; HDAC4:
    Histone deacetylase 4; IHH: Indian Hedgehog; YAP: Yes-associated protein; SIRT1:
    Silent mating type information regulator 2 homolog 1; XAV939, IWP-2, PKF and DKK1
    are representative Wnt/β-catenin inhibitors in suppressing hypertrophy.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR2
  - SMAD5
  - SMAD1
  - GARS1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DKK1
  - AXIN1
  - AXIN2
  - CTNNB1
  - LRP6
  - LRP5
  - APC
  - PROC
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3A
  - GSK3B
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - IHH
  - EZH2
  - DOT1L
  - PTCH1
  - RUNX2
  - RUNX3
  - MEF2A
  - MYEF2
  - MEF2C
  - MEF2D
  - MEF2B
  - YAP1
  - SMO
  - SMOX
  - GLI1
---
